跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LISORIL lisinopril 2.5mg (as dihydrate) tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
LISORIL lisinopril 2.5mg (as dihydrate) tablet blister pack
Approved
STANDARD
LISORIL lisinopril 2.5mg (as dihydrate) tablet blister pack
Ipca Pharma (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
817a3cc088233551
Company
Ipca Pharma (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
817a3cc088233551
Product Name
LISORIL lisinopril 2.5mg (as dihydrate) tablet blister pack
Artg Id
106491
Artg Name
LISORIL lisinopril 2.5mg (as dihydrate) tablet blister pack
Sponsor
Ipca Pharma (Australia) Pty Ltd
Company Detail Path
/organization/ipca-pharma-australia-pty-ltd
Artg Date
2006-07-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/fbcaad6fda9c599889274b72c8ff5fb2.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
817a3cc088233551
Type
Standard
Back to TGA Approvals
